Both lethal and edema toxins of bacillus anthracis disrupt the human dendritic cell chemokine network

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Cleret Buhot, Aurélie ^a,b   Mathieu, Jacques ^a   Tournier, Jean Nicolas ^a   Quesnel Hellmann, Anne ^a  

^a INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CHEMOKINE; EDEMA TOXIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 8; LETHAL TOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS ANTHRACIS; CELL ACTIVATION; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PROTEIN SYNTHESIS INHIBITION; TOXIN ANALYSIS;

ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-8; NEUTROPHIL INFILTRATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865305365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043266     Document Type: Article

References (28)

1. Young JA, Collier RJ, (2007) Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem 76: 243-265.
2. Tonello F, Montecucco C, (2009) The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity. Mol Aspects Med 30: 431-438.
3. Tang WJ, Guo Q, (2009) The adenylyl cyclase activity of anthrax edema factor. Mol Aspects Med 30: 423-430.
4. Tournier JN, Rossi Paccani S, Quesnel-Hellmann A, Baldari CT, (2009) Anthrax toxins: a weapon to systematically dismantle the host immune defenses. Mol Aspects Med 30: 456-466.
5. Joshi SK, Lang GA, Larabee JL, Devera TS, Aye LM, et al. (2009) Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy. PLoS Pathog 5: e1000588.
6. Klezovich-Benard M, Corre JP, Jusforgues-Saklani H, Fiole D, Burjek N, et al. (2012) Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins. PLoS Pathog 8: e1002481.
7. Liu S, Miller-Randolph S, Crown D, Moayeri M, Sastalla I, et al. (2010) Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe 8: 455-462.
8. Heath WR, Carbone FR, (2009) Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 10: 1237-1244.
9. Rot A, von Andrian UH, (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22: 891-928.
10. Alcami A, (2003) Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3: 36-50.
11. Cleret A, Quesnel-Hellmann A, Vallon-Eberhard A, Verrier B, Jung S, et al. (2007) Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J Immunol 178: 7994-8001.
12. Cleret A, Quesnel-Hellmann A, Mathieu J, Vidal D, Tournier JN, (2006) Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection. J Infect Dis 194: 86-94.
13. Tournier JN, Quesnel-Hellmann A, Mathieu J, Montecucco C, Tang WJ, et al. (2005) Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol 174: 4934-4941.
14. Agrawal A, Lingappa J, Leppla SH, Agrawal S, Jabbar A, et al. (2003) Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424: 329-334.
15. Maldonado-Arocho FJ, Bradley KA, (2009) Anthrax edema toxin induces maturation of dendritic cells and enhances chemotaxis towards macrophage inflammatory protein 3beta. Infect Immun 77: 2036-2042.
16. Guidi-Rontani C, Levy M, Ohayon H, Mock M, (2001) Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol 42: 931-938.
17. Brittingham KC, Ruthel G, Panchal RG, Fuller CL, Ribot WJ, et al. (2005) Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol 174: 5545-5552.
18. Pickering AK, Osario M, Lee GM, Grippe VK, Bray M, et al. (2004) Cytokine Response to Infection with Bacillus anthracis Spores. Infect Immun 72: 6382-6389.
19. Rossi Paccani S, Benagiano M, Capitani N, Zornetta I, Ladant D, et al. (2009) The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling. PLoS Pathog 5: e1000325.
20. Quesnel-Hellmann A, Cleret A, Vidal DR, Tournier JN, (2006) Evidence for adjuvanticity of anthrax edema toxin. Vaccine 24: 699-702.
21. Duverger A, Jackson RJ, van Ginkel FW, Fischer R, Tafaro A, et al. (2006) Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens. J Immunol 176: 1776-1783.
22. Comer JE, Chopra AK, Peterson JW, Konig R, (2005) Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Infect Immun 73: 8275-8281.
23. Batty S, Chow EM, Kassam A, Der SD, Mogridge J, (2006) Inhibition of mitogen-activated protein kinase signalling by Bacillus anthracis lethal toxin causes destabilization of interleukin-8 mRNA. Cell Microbiol 8: 130-138.
24. Raymond B, Batsche E, Boutillon F, Wu YZ, Leduc D, et al. (2009) Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification. PLoS Pathog 5: e1000359.
25. Garraud K, Cleret A, Mathieu J, Fiole D, Gauthier Y, et al. (2012) Differential role of the interleukin-17 axis and neutrophils in resolution of inhalational anthrax. Infect Immun 80: 131-142.
26. Moayeri M, Sastalla I, Leppla SH, (2012) Anthrax and the inflammasome. Microbes Infect 14: 392-400.
27. Levinsohn JL, Newman ZL, Hellmich KA, Fattah R, Getz MA, et al. (2012) Anthrax lethal factor cleavage of nlrp1 is required for activation of the inflammasome. PLoS Pathog 8: e1002638.
28. Frew BC, Joag VR, Mogridge J, (2012) Proteolytic processing of nlrp1b is required for inflammasome activity. PLoS Pathog 8: e1002659.